Stem Cell Therapy for Diabetes
糖尿病干细胞治疗
Duration
2-4 weeks treatment; 6-12 months monitoring
Recovery
1-2 weeks post-procedure; metabolic benefits develop over 3-6 months
Savings
~66% vs US
Average savings compared to US prices
Investigational stem cell therapy for type 1 and type 2 diabetes aiming to restore pancreatic beta cell function and improve insulin sensitivity. Chinese research hospitals conduct clinical trials using mesenchymal stem cells, induced pluripotent stem cells, and encapsulated islet-like cells. Programs combine cell therapy with metabolic management and lifestyle optimization.
Metabolic Assessment
C-peptide levels, HbA1c, islet autoantibody testing, and comprehensive metabolic panel
Duration: 2-3 daysCell Therapy Planning
Protocol selection based on diabetes type, residual beta cell function, and treatment goals
Duration: 1 weekStem Cell Administration
Intravenous MSC infusion or interventional delivery to pancreatic vasculature
Duration: 1-3 sessionsMetabolic Monitoring
Serial C-peptide, insulin requirements, HbA1c tracking, and dose adjustments over 12 months
Duration: Monthly for 12 months- Potential to reduce insulin requirements or achieve insulin independence
- Chinese hospitals have extensive diabetes stem cell trial experience
- Combined with comprehensive metabolic optimization
- May slow or halt autoimmune destruction in type 1 diabetes
- Experimental treatment — not standard of care
- Variable response rates across patients
- Potential for transient fever and infusion reactions
- Long-term durability of benefit uncertain
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.